Elyssa Noce, APRN
Adult Health · New Haven, CTNPI 1861913428
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,625 of the $5,389 with a category attached, or 67.3%. Otsuka Pharmaceutical Development & Commercialization, Inc. accounts for 75.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $2,735 and has fallen 94.7% since, to $146 in 2025. Among adult health clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 15 payments — averaging $359.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$4K
- Bayer$1K
- Aurinia Pharma U.S., Inc.$125
- Cequr Corporation$89
- Biohaven Pharmaceutical Holding Company Ltd.$53
- Amgen$29
- plus $31 from 2 others
What the payments were for
- Consulting fees$3,62567%
- Travel & lodging$1,19522%
- Food & beverage$56610%
- Education$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $4,050 |
| Bayer | 1 | $1,012 |
| Aurinia Pharma U.S., Inc. | 1 | $125 |
| Cequr Corporation | 1 | $89 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $53 |
| Amgen | 1 | $29 |
| Novo Nordisk | 1 | $28 |
| Travere Therapeutics, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,389 in reported general payments places this provider in the 90th percentile of 418 adult health providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JynarqueTolvaptan | 25 | $471,218 |
| JardianceEmpagliflozin | 113 | $93,547 |
| FarxigaDapagliflozin Propanediol | 89 | $68,525 |
| AranespDarbepoetin Alfa In Polysorbat | 50 | $66,324 |
| Droxidopa | 49 | $35,168 |
| LokelmaSodium Zirconium Cyclosilicate | 34 | $29,185 |
| KerendiaFinerenone | 30 | $23,146 |
| EntrestoSacubitril/Valsartan | 17 | $21,624 |
| Sevelamer Carbonate | 78 | $18,118 |
| LinzessLinaclotide | 13 | $13,122 |
| Potassium Citrate ErPotassium Citrate | 77 | $8,965 |
| Cinacalcet Hcl | 37 | $8,492 |
| EliquisApixaban | 13 | $7,465 |
| Midodrine Hcl | 105 | $6,176 |
| ProcritEpoetin Alfa | 18 | $5,354 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenAranesp | $29 | $66,32450 claims |
| BayerKerendia | $1,012 | $23,14630 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 418 adult health providers in Connecticut.
Other adult health in New Haven
- Kellie HaleNew Haven$27K
- Gena CoelhoNew Haven$7K
- Amy DavisNew Haven$6K
- Emily DuffieldNew Haven$4K
- Kathleen CrawfordNew Haven$4K
- Leah EhleManchester$418K
- Laura MulkaWethersfield$306K
- Gretchen MichaelsonSouth Windsor$169K
- Kimberly RyanWethersfield$74K
- Kathryn JackMeriden$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.